93 results
6-K
EX-99.1
BLU
Bellus Health Inc
28 Jun 23
GSK completes acquisition of BELLUS Health
11:05am
patients suffer from chronic cough, with 10 million patients globally and 6 million in the United States (US) and European Union (EU) suffering from RCC
6-K
EX-99.1
BLU
Bellus Health Inc
19 May 23
Current report (foreign)
5:27pm
. There are currently no approved treatments for this condition in the United States, European Union or the United Kingdom.
The Parent is a global … recognize any new union, works council or similar entities or other organized employees;
(xix)
enter into any Contract that materially limits the freedom
6-K
EX-99.2
BLU
Bellus Health Inc
12 May 23
Condensed Consolidated Interim Financial Statements of
4:32pm
suffer from chronic cough, including the United States, nations in the European Union and the United Kingdom. This represents approximately 26 million
6-K
EX-99.1
BLU
Bellus Health Inc
12 May 23
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
4:02pm
for this condition in the United States, European Union or the United Kingdom.
BELLUS Health Inc.
275 Armand-Frappier Blvd.
Laval, Quebec, Canada
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
with respect to any current or former Company Associate or other Contract with a union or employee association, including a neutrality or accretion … 21 C.F.R. Parts 210 and 211), Health Canada, the European Medicines Agency or under the European Union guide to Good Manufacturing Practice for medical
6-K
EX-99.1
enw xpnkcvbrv7qel30
18 Apr 23
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
6:02am
6-K
EX-99.1
bn0cevdscnos9g203z
5 Apr 23
BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating
7:01am
6-K
EX-99.1
bz3gi2q1
29 Mar 23
Current report (foreign)
5:26pm
6-K
EX-99.2
jtqst44z3e
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
SUPPL
3kysfsnu 8l
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
EX-99.1
1byb htblo2sfcs
14 Nov 22
Open Market Sale Agreementsm
5:19pm
F-10
ghwtgu
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
EX-99.2
ntyh0 qmf0u8
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
SUPPL
emy7znd4bjm osf
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
EX-99.2
1erltc756466nf 960
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
1a6o jigv4b
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
EX-99.2
96g5d4673n29
11 May 22
Condensed Consolidated Interim Financial Statements of
5:05pm
6-K
EX-99.1
eiq29d
5 Apr 22
Current report (foreign)
4:07pm
40-F
EX-99.3
v7nr vfi92v
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.1
ia4tnpsm
23 Feb 22
Annual report (Canada)
5:20pm